Home › Funds › M.D. Sass, LLC › APH

M.D. Sass, LLC position in APH

AMPHENOL CORP · Technology

M.D. Sass, LLC reported holding 63,907 shares of APH (AMPHENOL CORP) in its Q2 2026 13F filing — a position valued at US$11.3M, representing 0.75% of its reported portfolio and ranking #25 among its reported holdings. M.D. Sass, LLC has disclosed APH holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)63.91K sh
Reported value held$11.27M
Portfolio Weight0.75%
First reportedQ1 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How M.D. Sass, LLC's APH position evolved

M.D. Sass, LLC first disclosed a stake in APH in Q1 2025 at 1,045,366 shares (US$68.6M). Across 6 filings, M.D. Sass, LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 63,907 shares valued at US$11.3M — an increase of 7,725 shares quarter over quarter.. Notable position changes include a 42% trim in Q2 2025 (shares rose 25% over the following quarter), a 44% trim in Q3 2025 (shares rose 9% over the following quarter), a 83% trim in Q4 2025 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 1.05M $68.57M New
Q2 2025 604.80K $59.72M Reduce
Q3 2025 336.40K $41.63M Reduce
Q4 2025 56.28K $7.61M Reduce
Q1 2026 56.18K $7.10M Hold
Q2 2026 63.91K $11.27M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About APH and 13F data

APH (AMPHENOL CORP) is a Technology company. 51 other funds we track also report a position in APH — the largest reported positions include BlackRock Inc (US$17.85B), Fidelity Management & Research (FMR) (US$12.44B), Capital International Investors (US$7.59B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding APH

All APH fund holders →

FAQ

How long has M.D. Sass, LLC held APH?

M.D. Sass, LLC has disclosed APH holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is M.D. Sass, LLC's current position in APH?

As of Q2 2026, M.D. Sass, LLC holds 63.91K shares of APH (AMPHENOL CORP), valued at $11.27M, representing 0.75% of its reported portfolio and ranking #25.

Has M.D. Sass, LLC been buying or selling APH?

In the latest 13F filing (Q2 2026), M.D. Sass, LLC increased its position in APH.

Which other funds hold APH?

Other major institutional holders of APH include BlackRock Inc, Fidelity Management & Research (FMR), Capital International Investors, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.